Suchergebnisse - (Subject:"Treatment Outcome")

PubPharm (6)

1

First-in-human phase I/II study of NEOD001 in patients with light chain amyloidosis and persistent organ dysfunction

enthalten in: Journal of clinical oncology | February 8, 2016

von Gertz, M. | Landau, H. | Comenzo, R. | +11

2

Treatment and outcome of patients with metastatic NSCLC : a retrospective institution analysis of 493 patients

enthalten in: Respiratory research | 18 December 2013

von Reinmuth, N. | Payer, N. | Muley, T. | +4

3

Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia

enthalten in: Journal of clinical oncology | March 21, 2011

von Hehlmann, R. | Lauseker, M. | Jung-Munkwitz, S. | +17

4

Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients : the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study

enthalten in: Cerebrovascular diseases | April 16, 2009

von Bousser, M. | Amarenco, P. | Chamorro, A. | +6

5

Effects of low-dose warfarin and regional chemotherapy on survival in patients with pancreatic carcinoma

enthalten in: Scandinavian journal of gastroenterology | 2006

von Nakchbandi, W. | Müller, H. | Singer, M. | +2

6

Inhaled nitric oxide does not enhance lipid peroxidation in patients with acute respiratory distress syndrome

enthalten in: Critical care medicine | 2000/10/01

von Weigand, M. | Snyder-Ramos, S. | Möllers, A. | +5

1
[1]